Literature DB >> 11278416

Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases.

K Shirotani1, S Tsubuki, N Iwata, Y Takaki, W Harigaya, K Maruyama, S Kiryu-Seo, H Kiyama, H Iwata, T Tomita, T Iwatsubo, T C Saido.   

Abstract

To identify the amyloid beta peptide (Abeta) 1-42-degrading enzyme whose activity is inhibited by thiorphan and phosphoramidon in vivo, we searched for neprilysin (NEP) homologues and cloned neprilysin-like peptidase (NEPLP) alpha, NEPLP beta, and NEPLP gamma cDNAs. We expressed NEP, phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PEX), NEPLPs, and damage-induced neuronal endopeptidase (DINE) in 293 cells as 95- to 125-kDa proteins and found that the enzymatic activities of PEX, NEPLP alpha, and NEPLP beta, as well as those of NEP and DINE, were sensitive to thiorphan and phosphoramidon. Among the peptidases tested, NEP degraded both synthetic and cell-secreted Abeta1-40 and Abeta1-42 most rapidly and efficiently. PEX degraded cold Abeta1-40 and NEPLP alpha degraded both cold Abeta1-40 and Abeta1-42, although the rates and the extents of the digestion were slower and less efficient than those exhibited by NEP. These data suggest that, among the endopeptidases whose activities are sensitive to thiorphan and phosphoramidon, NEP is the most potent Abeta-degrading enzyme in vivo. Therefore, manipulating the activity of NEP would be a useful approach in regulating Abeta levels in the brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278416     DOI: 10.1074/jbc.M008511200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

Review 1.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

2.  Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease.

Authors:  Salim S El-Amouri; Hong Zhu; Jin Yu; Robert Marr; Inder M Verma; Mark S Kindy
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

3.  Contributions of degradation and brain-to-blood elimination across the blood-brain barrier to cerebral clearance of human amyloid-β peptide(1-40) in mouse brain.

Authors:  Shingo Ito; Kohta Matsumiya; Sumio Ohtsuki; Junichi Kamiie; Tetsuya Terasaki
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

Review 4.  Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.

Authors:  Shu-Hui Xin; Lin Tan; Xipeng Cao; Jin-Tai Yu; Lan Tan
Journal:  Neurotox Res       Date:  2018-04-07       Impact factor: 3.911

Review 5.  Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.

Authors:  E Malito; R E Hulse; W-J Tang
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

6.  Proteomic analysis of the amyloid precursor protein fragment C99: expression in yeast.

Authors:  Louis J Sparvero; Sarah Patz; Jeffrey L Brodsky; Christina M Coughlan
Journal:  Anal Biochem       Date:  2007-08-10       Impact factor: 3.365

7.  Flavanols, mild cognitive impairment, and Alzheimer's dementia.

Authors:  Ami K Patel; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Med       Date:  2008-04-15

8.  Distinct subcellular patterns of neprilysin protein and activity in the brains of Alzheimer's disease patients, transgenic mice and cultured human neuronal cells.

Authors:  Li Zhou; Chunsheng Wei; Wei Huang; David A Bennett; Dennis W Dickson; Rui Wang; Dengshun Wang
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

Review 9.  New Insights of a Neuronal Peptidase DINE/ECEL1: Nerve Development, Nerve Regeneration and Neurogenic Pathogenesis.

Authors:  Sumiko Kiryu-Seo; Kenichi Nagata; Takaomi C Saido; Hiroshi Kiyama
Journal:  Neurochem Res       Date:  2018-10-24       Impact factor: 3.996

Review 10.  Transgenic Drosophila models of Alzheimer's disease and tauopathies.

Authors:  Kanae Iijima-Ando; Koichi Iijima
Journal:  Brain Struct Funct       Date:  2009-12-05       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.